Making sense of the global health crisis: Policy narratives, conflict, and global health governance

Journal of Health Politics, Policy and Law

Volumn 37, Issue 2, 2012, Pages 253-295

  Ney, Steven ^a  

^a JACOBS UNIVERSITY BREMEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFLICT; HEALTH; HEALTH CARE DISPARITY; HEALTH CARE POLICY; INTERNATIONAL COOPERATION; MANAGEMENT; ORGANIZATION AND MANAGEMENT;

CONFLICT (PSYCHOLOGY); HEALTH POLICY; HEALTHCARE DISPARITIES; INTERNATIONAL COOPERATION; POLICY MAKING; PRIVATE SECTOR; PUBLIC SECTOR; WORLD HEALTH;

EID: 84860530742     PISSN: 03616878     EISSN: 15271927     Source Type: Journal    
DOI: 10.1215/03616878-1538620     Document Type: Article

References (94)

1. Adler, E., and P. Haas. 1992. Conclusion: Epistemic Communities, World Order, and the Creation of a Reflective Research Program. International Organization 46:367-389.
2. Benson, J. 2001. The Impact of Privatisation on Access in Tanzania. Social Science and Medicine 52:1903-1915.
3. Blunden, F., and T. Smith. 2005. What Does Choice Mean? How Can It Be Made More Meaningful. Health Policy Review 1:16-35.
4. Bornstein, D. 2004. How to Change the World: Social Entrepreneurs and the Power of New Ideas. Oxford: Oxford University Press.
5. British Medical Association (BMA). 2004. British Medical Association Written Submission to the Public Administration Select Committee Inquiry - Choice and Voice in Public Services. www.bma.org.uk/ap.nsf/Content/choiceandvoice~defining (accessed October 1, 2008).
6. Brown, G. W. 2010. Safeguarding Deliberative Global Governance: The Case of the Global Fund to Fight AIDS, Tuberculosis, and Malaria. Review of International Studies 36:511-530.
7. Bundesärztekammer. 2003. Gesundheitspolitische Grundsätze der deutschen Ärzteschaft (The German Medical Profession's Principles of Health Policy). www .bundesaerztekammer.de/page.asp?his=0.5 (accessed February 23, 2008).
8. Buse, K., and A. M. Harmer. 2007. Seven Habits of Highly Effective Global Public-Private Health Partnerships: Practice and Potential. Social Science and Medicine 64:259-271.
9. Depledge, J. 2006. The Opposite of Learning: Ossification in the Climate Change Regime. Global Environmental Politics 6 (1):1-22.
10. Dodgson, R., K. Lee, and N. Drager. 2002. Global Health Governance: A Conceptual Review. Discussion Paper No. 1. Geneva: World Health Organization and London School of Hygiene and Tropical Medicine.
11. Dryzek, J. 1993. Policy Analysis and Planning: From Science to Arguments. In The Argumentative Turn in Policy Analysis and Planning, ed. F. Fischer and J. Forester, 214-233. Durham, NC: Duke University Press.
12. European Commission. 2007. Communication from the Commission to the Council, the European Parliament, the Economic and Social Committee and the Committee of the Regions on the Health Strategy of the European Community. Brussels: European Commission.
13. European Public Health Alliance. 2008. EPHA Response to the Consultation Regarding Europe's Social Reality: A " Stocktaking." January. Brussels: EPHA. www .epha.org/IMG/pdf/EPHA_Response_SR_Stocktaking.pdf.
14. Fidler, D. P. 2007. Architecture amidst Anarchy: Global Health's Quest for Governance. Global Health Governance 1 (1):1-17.
15. Fidler, D. P 2009. After the Revolution: Global Health Politics in a Time of Economic Crisis and Threatening Future Trends. Global Health Governance 2 (2):1-21.
16. Fidler, D. P., and L. O. Gostin. 2006. The New International Health Regulations: An Historic Development for International Law and Public Health. Journal of Law, Medicine, and Ethics 34:85-94.
17. Fischer, F. 2003. Reframing Public Policy: Discursive Politics and Deliberative Practices. Oxford: Oxford University Press.
18. Fischer, F., and J. Forester, eds. 1993. The Argumentative Turn in Policy Analysis and Planning. Durham, NC: Duke University Press.
19. GlaxoSmithKline (GSK). 2005. Pricing and Reimbursement: Key Principles from GSK. June. Brentford, UK: GSK. www.gsk.com/policies/GSK-pricing-and-reimbursement .pdf (accessed October 26, 2010).
20. GlaxoSmithKline (GSK).2006a. Key Aspects of a Sustainable Healthcare System. September. Brentford, UK: GSK. www.gsk.com/policies/GSK-and-key-aspects-of-a-sustainable-healthcare-system.pdf (accessed October 26, 2010).
21. GlaxoSmithKline (GSK). 2006b. Human Race: Corporate Responsibility Report 2006. Corporate Responsibility Report. Brentford, UK: GSK. www.gsk.com/responsibility/downloads/CR-Report-2006.pdf (accessed October 2, 2008).
22. GlaxoSmithKline (GSK).. 2009. GlaxoSmithKline Statement in Response to Paul Hunt's Report on GSK (A/HRC/11/12/Add.2). June. Brentford, UK: GSK. www.gsk.com/responsibility/ downloads/GlaxoSmithKline-Statement-in-response-to-the-Paul-Hunt-Report-on-GSK. pdf (accessed March 23, 2010).
23. GlaxoSmithKline (GSK). 2010. The Counterfeiting of Healthcare Products. www.gsk.com/policies/ GSK-on-counterfeiting-of-healthcare-products. pdf (accessed October 26, 2010). Global Health Council. 2006a. Health Equity for the World's Children Would Save Millions of Lives. Policy Brief. August. Washington, DC: GHC.
24. GlaxoSmithKline (GSK). 2006b. Decrease Violence to Decrease Risk of HIV among Women and Girls. Policy Brief. Washington, DC: GHC.
25. GlaxoSmithKline (GSK). 2009. Understanding Private Sector Involvement in Health Systems. Research Brief. August. Washington, DC: GHC.
26. GlaxoSmithKline (GSK). 2010. Maternal, Newborn, Child, and Reproductive Health. GHC Position Paper. May. Washington, DC: GHC.
27. Gostin, L. O., and E. A. Mok. 2009. Grand Challenges in Global Health Governance. British Medical Bulletin 90:7-18.
28. Habermas, J. 1987. Theorie des Kommunikativen Handelns Bd.2 (vierte Auflage). Frankfurt am Main: Suhrkamp.
29. Hansen, F. 2007. SelfCare: Essentials of 21st Century Health Care Reform. Adam Smith Institute. www.adamsmith.org/think-piece/health/selfcare-%11-essentials-of-21st-century-health-care-reform/ (accessed October 2, 2008). Health Action International (HAI). 2009. Response to the DG Competition Consultation. HAI Europe Response. January 31. Amsterdam: HAI. haiweb.org/07032009/31%20Jan%202009%20HAI%20Europe%20Response%20to%20DG%20Competition%20Consultation.pdf.
30. Heclo, H. 1974. Modern Social Politics in Britain and Sweden: From Relief to Income Maintenance. New Haven, CT: Yale University Press.
31. Held, D., and A. McGrew. 2007. Globalization/Anti-Globalization. 2nd ed. Malden, MA: Polity. International Council of Nurses (ICN). 2001. Publicly Funded Accessible Health Services. Position Statement. Geneva: ICN.
32. Heclo, H.. 2008a. Rights of Children. Position Statement. Geneva: ICN.
33. Heclo, H.. 2008b. The Paris Declaration. Nursing Matters: Fact Sheet. November. Geneva: ICN.
34. Heclo, H. 2009a. ICN on Poverty and Health: Breaking the Link. Nursing Matters: Fact Sheet. Geneva: ICN.
35. Heclo, H. 2009b. The Nursing and Social Care Interface. Nursing Matters: Fact Sheet. April. Geneva: ICN.
36. International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). 2007. The Pharmaceutical Innovation Platform: Meeting Essential Global Health Needs.November. Geneva: IFPMA.
37. International Labour Office (ILO). 2007. Social Health Protection: An ILO Strategy towards Universal Access to Health Care. Social Security Policy Briefing. Geneva: ILO.
38. International Social Security Association. 2007. Investing in People's Health: Towards Strengthening Health Promotion and Prevention in Social Health Insurance Systems. Technical Commission of Medical Care and Sickness Insurance. Geneva: ISSA and World Health Organization.
39. Islam, A., and M. Zaffar Tahir. 1999. Health Sector Reform in South Asia: New Challenges and Constraints. Health Policy 60:151-169.
40. Johnson and Johnson. 2010a. What Drives Health Care Spending. jnj.com/connect/ pdf/views-positions-pdf/ what-drives-health-care-spending. pdf (accessed October 14, 2010).
41. Islam, A. 2010b. Value of Innovation in New Products. jnj.com/connect/pdf/views-positions-pdf/value-of-innovation-in-new-products.pdf (accessed October 14, 2010).
42. Islam, A. 2010c. The Promise of Health Care. jnj.com/connect/pdf/views-positions -pdf/ the-promise-of-health-care. pdf (accessed October 14, 2010).
43. Islam, A. 2010d. Intellectual Property. jnj.com/connect/pdf/views-positions-pdf/ intellectual-property. pdf (accessed October 14, 2010).
44. Kickbusch, I., and L. Payne. 2004. Constructing Global Public Health in the 21st Century. Meeting on Global Health Governance and Accountability, Harvard University, Cambridge, MA, June , 2004.
45. Kingdon, J. W. 1984. Agendas, Alternatives, and Public Policies. Boston: Little, Brown.
46. Lancet Editors. 2007. Implementation of Tobacco Control Policies Proves Hard to Do. Lancet 369:2133.
47. Lee, K. 2010. Civil Society Organisations and the Function of Global Health Governance: What Role within Intergovernmental Organisations? Global Health Governance 3 (2):1-20.
48. Musgrove, P., and R. Zeramdini. 2001. A Summary Description of Health Financing in WHO Member States. CMH Working Paper Series WG3:3.
49. Negri, D., and C. Bollars. 2007. EPHA Response to DG SANCO Discussion Document. Future Challenges Paper: 2009-2014. December. Brussels: EPHA. www .epha.org/IMG/pdf/EPHA_Response_Future_Challenges-1.pdf.
50. Ney, Steven. 2009. Resolving Messy Policy Problems. London: EarthScan.
51. Ney, Steven. 2011. " Understanding the Global Health Crisis: Contending Policy Narratives and Global Health Governance" (working paper, School of Humanities and Social Sciences, Jacobs University, Bremen).
52. Novartis. 2005a. Access to Medicines in the Developing World. Position paper. November. Basel, Switzerland: Novartis. corporatecitizenship.novartis.com/patients/ access-medicines.shtml.
53. Novartis. 2005b. Counterfeit Medicines. Position paper. November. Basel, Switzerland: Novartis.corporatecitizenship.novartis.com/patients/patient-safety/anti-counterfeiting-efforts.shtml.
54. Novartis. 2008. Human Rights. Position paper. March. Basel, Switzerland: Novartis. corporatecitizenship.novartis.com/downloads/business-conduct/human_rights _external.pdf.
55. Organisation for Economic Co-operation and Development. 2004. Towards High-Performing Health Systems. Summary Report. Paris: OECD.
56. Oxfam International. 2009. Blind Optimism: Challenging the Myth about Private Health Care in Poor Countries. Oxfam Briefing Paper. February 12. London: Oxfam International.
57. Oxfam, VSO, and Save the Children. 2002. Beyond Philanthropy: The Pharmaceutical Industry, Corporate Responsibility, and the Developing World. July. London: Oxfam, VSO, and Save the Children.
58. People's Health Movement (PHM). 2000. People's Charter for Health. Bangalore: PHM. www.phmovement.org/charter/pch-index.html (accessed October 2, 2008).
59. People's Health Movement (PHM), Medact, and Global Equity Gauge Alliance (GEGA). 2005. Global Health Watch: 2005-2006: An Alternative World Health Report. London: Zed Books.
60. Rein, M., and D. Schön. 1993. Reframing Policy Discourse. In The Argumentative Turn in Policy Analysis and Planning, ed. F. Fischer and J. Forester, 145-166. Durham, NC: Duke University Press.
61. Rein, M. 1994. Frame Reflection: Toward the Resolution of Intractable Policy Controversies. New York: Basic Books. Richter, J. 2004. Public-Private Partnerships for Health: A Trend with No Alternatives. Development 47 (2):43-48.
62. Rittel, H., and M. Webber. 1973. Dilemmas in a General Theory of Planning. Policy Sciences 4:155-169.
63. Roche. 2009. Roche Position on Personalised Healthcare. Basel, Switzerland: Roche. www.roche.com/position_personalised_healthcare.pdf (accessed October 17, 2010).
64. Roe, E. 1994. Narrative Policy Analysis: Theory and Practice. Durham, NC: Duke University Press.
65. Ruger, J. P., and D. Yach. 2008. The Global Role of the World Health Organisation. Global Health Governance 2 (2):2-11.
66. Sabatier, P., and H. Jenkins-Smith. 1993. Policy Change and Learning: An Advocacy Coalition Approach. Boulder, CO: Westview.
67. Saltman, R. B., and O. Ferrousier-Davis. 2000. The Concept of Stewardship in Health Policy. Bulletin of the World Health Organisation 78:732-739.
68. Sanders, D. 2003. Twenty-Five Years of Primary Health Care: Lessons Learned and Proposals for Revitalisation. In Health for All Now - Revive Alma-Ata, ed.R. Narayan and P. V. Unnikrishnn, 5-10. Bangalore: Books for Change.
69. Schattschneider, E. E. 1960. The Semi-Sovereign People. New York: Rinehart and Winston.
70. Schiff, G. D., A. B. Bindman, T. A. Brennan, T. Bodenheimer, C. Clancy, O. Fein, I. Hellander, et al. 1994. A Better-Quality Alternative: Single-Payer National Health System Reform. Journal of the American Medical Association 272:803-808.
71. Schrecker, T., R. Labonté, and R. de Vogli. 2008. Globalisation and Health: The Need for a Global Vision. Lancet 372:1670-1676.
72. Scoones, I., and P. Forster. 2008. The International Response to Highly Pathogenic Avian Influenza: Science, Policy, and Politics. STEPS Centre Working Paper No. 10. Brighton, UK: STEPS Centre.
73. Smith, R. D. 2010. The Role of Economic Power in Influencing the Development of Global Health Governance. Global Health Governance 3 (2):1-12.
74. Sridhar, D., S. Khagram, and T. Pang. 2009. Are Existing Governance Structures Equipped to Deal with Today's Global Health Challenges - towards Systematic Coherence in Scaling Up. Global Health Governance 2 (2):1-25.
75. Steger, M. B. 2009. Globalisation: A Very Short Introduction. Oxford: Oxford University Press.
76. Stone, D. 2002. Policy Paradox: The Art of Political Decision Making, rev. ed. London: Norton.
77. Thompson, M., S. Rayner, and S. Ney. 1998. Risk and Governance Part II: Policy in a Complex and Plurally Perceived World. Government and Opposition 33:330-354.
78. Union for International Cancer Control. 2008. World Cancer Declaration. Geneva: UICC. uicc.agenceinovae.com/sites/uicc.agenceinovae.com/files/wcden09low.pdf (accessed October 12, 2010).
79. Vasella, D. 2004. The Right to Health: The Novartis Position. In The Right to Health: A Duty for Whom, ed. K. Leisinger, 42-44. International Symposium Report. Basel, Switzerland: Novartis Foundation for Sustainable Development.
80. Verweij, M., and M. Thompson, eds. 2006. Clumsy Solutions for a Complex World: Governance, Politics, and Plural Perceptions. Basingstoke, UK: Palgrave Macmillan.
81. Wallace, P. 2004. Survey: The Health of Nations. Economist, June 15. www.economist.com/node/2895909.
82. Werner, D. 2003. The Alma-Ata Declaration and the Goal of " Health for All" 25 Years Later - Keeping the Dream Alive. In Health for All Now - Revive Alma-Ata, ed.R. Narayan and P. V. Unnikrishnn, 15-18. Bangalore: Books for Change.
83. Wikipedia. 2010. List of Pharmaceutical Companies. en.wikipedia.org/wiki/List_of _pharmaceutical_companies (accessed March 10, 2010).
84. World Bank. 1993. World Development Report 1993: Investing in Health. Washington, DC: World Bank.
85. World Federation of Occupational Therapists (WFOT). 2006. World Federation of Occupational Therapists Position Statement on Human Rights. World Federation Position Paper. July 21. ForrestField, Australia: WFOT. www.wfot.org/documents.asp?cat=31.
86. World Health Organization (WHO). 2000. The World Health Report 2000: Health Systems - Improving Performance. Geneva: WHO.
87. World Health Organization (WHO). 2008. World Health Report 2008: Primary Health Care (Now More Than Ever). Geneva: WHO.
88. World Health Organization and United Nations Children's Fund. 1978. Primary Health Care: Report of the International Conference on Primary Health Care. International Conference at Alma-Ata, USSR, September 6-12. Geneva: WHO.
89. World Heart Federation. 2005. World Heart Federation Strongly Supports WHO Report Published Today on Preventing Chronic Diseases. News release, October 5. www.world-heart-federation.org/press/news-old/advocacy/global-health-agenda/?0=.
90. World Medical Association (WMA). 2006. WMA Statement on Access to Health Care. WMA General Assembly, October. Pilanesberg, South Africa: WMA.
91. World Medical Association (WMA). 2008. WMA Declaration of Seoul on Professional Autonomy and Clinical Independence. WMA General Assembly, October. Seoul: WMA.
92. World Medical Association (WMA). 2009. WMA Statement on Inequalities in Health. WMA General Assembly, October. New Delhi: WMA.
93. World Vision. 2009. Who's Counting? 9.2 Million Children - the Cost of Inaction on Child Health. World Vision International Policy Briefing No. 1. Monrovia, CA:World Vision. www.wvi.org/wvi/wviweb.nsf/maindocs/80AD68CE4566FB13882 574CC0073A46E?opendocument (accessed October 25, 2010).
94. Yunus, M. 2007. Creating a World without Poverty: Social Business and the Future of Capitalism. New York: Public Affairs.